REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $200,000 | -48.3% | 7,578 | -30.5% | 0.00% | -81.8% |
| Q3 2019 | $387,000 | -82.2% | 10,900 | -74.2% | 0.01% | -85.7% |
| Q2 2019 | $2,173,000 | -57.5% | 42,300 | -52.5% | 0.08% | -56.5% |
| Q1 2019 | $5,107,000 | +163.1% | 89,100 | +246.7% | 0.18% | +105.8% |
| Q3 2018 | $1,941,000 | -75.4% | 25,700 | -76.6% | 0.09% | -79.9% |
| Q2 2018 | $7,886,000 | +428.2% | 109,900 | +119.8% | 0.43% | +282.1% |
| Q1 2018 | $1,493,000 | -71.7% | 50,000 | -68.5% | 0.11% | -74.1% |
| Q4 2017 | $5,277,000 | +14.3% | 158,687 | +13.3% | 0.43% | +2.4% |
| Q3 2017 | $4,617,000 | +211.7% | 140,120 | +86.8% | 0.42% | +175.8% |
| Q2 2017 | $1,481,000 | -0.3% | 75,000 | -2.5% | 0.15% | +2.7% |
| Q1 2017 | $1,485,000 | +100.1% | 76,911 | +92.3% | 0.15% | +55.2% |
| Q4 2016 | $742,000 | – | 40,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |